WAKAMONO Launches The World's First Anti-Coronavirus Surgical Mask
These Nano Biotech Masks Have Been Proven Effective Against Covid-19 & More, With Data-Driven ResultsOctober 15, 2020 - WAKAMONO has launched an antimicrobial medical mask created to not only filter viruses and bacteria but to kill them on contact. The world's first Nano Biotech application mask, WAKAMONO utilizes a GECIDE FABRIC layer that is covered with millions of organic nanoparticles that "trap", weaken and destroy viruses and bacteria upon contact. This mask has been shown to be effective against 99% of the strains of SARS-CoV-2 which is the Human Coronavirus strain causing the COVID-19 pandemic. This unique mask is also capable of self-killing Coronavirus strains including strain NL63, 229E and inactivates influenza A H1N1 - the enveloped viruses and Poliovirus-I - the non-enveloped viruses. WAKAMONO Medical Mask kills 99.9% of pathogenic bacteria and has data-driven results available for further reference. In addition to the antiviral properties, WAKAMONO surgical masks meets and exceeds the highest FDA standards of the US, which is ASTM F2100 level 3 and European CE EN 14683 Type IIR. It is also certified biosafety (according to tests for in vitro cytotoxicity) and made with organic and natural components. The masks are free from any metal nanoparticles and has been tested/certified by independent labs including FDA, Eurofins and Pacific BioLabs and more. WAKAMONO is priced at $79.99 (box of 50), 2-4 (50 boxes) for $45 and 5 and more (50 boxes for $29. The masks are available for purchase now at https://wakamonobio.com/product/the-wakamono-mask. Additional imagery here
About WAKAMONO NANOBIOTECHNOLOGY LEADERS UNITE TO STAND WITH SCIENCE WAKAMONO is a science-led nanobiotechnology company that focus on the discovery, development, manufacturer of nanomaterial primarily for medical devices, food, functional foods, cosmetics. At WAKAMONO, we are blending our heart, science and ingenuity to create products to guide the future of people. Today, WAKAMONO is continuous to be at the forefront of research to prevent and protect diseases especially SARS-CoV-2 causing COVID-19 that continues to threaten lives. By applying Nano Biotech, we aspire to be the premier research and manufacturer-intensive biotechnology company in the world. For more information visit wakamonobio.com.
